Stay updated with breaking news from Abecma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As an oncologist, Kristen Hege first encountered cancer cell therapy research in the mid-1990s. Now as a Bristol Myers Squibb executive, she oversees efforts to improve the pharma giant’s first generation of cell therapies while also building a pipeline of next-generation treatments with better features and properties. ....
An FDA approval for Johnson & Johnson and Legend Biotech’s CAR-T therapy may be three months later than originally expected, but it still came through for the partners. ....
The FDA has accepted Bristol Myers Squibb's application for Breyanzi as a second-line treatment for relapsed or refractory large B-cell lymphoma. The regulator has assigned it priority review with a decision deadline of June 24. ....
The FDA has slapped a clinical hold on Takeda and Denali Therapeutics' phase 1-ready Alzheimer's candidate. Daiichi Sankyo is shutting down its Plexxikon R&D facility. Legend Biotech talks manufacturing learnings from Bristol Myers Squibb's CAR-T rival. ....
Mumbai: Global independent research firm RECMA has ranked Starcom India, part of Publicis Groupe India number one in new business in its ‘New Business Balance Report for 2021’. The research firm evaluates media agencies worldwide. The agency has gained the top position in competitive pitch wins across Consumer Products (CPG), New-Age, and App Economy which includes clients in ....